A federal appeals court reversed a Food and Drug Administration ruling that effectively blocked until June Mylan Pharmaceuticals Inc., Watson Laboratories Inc. and Lupin Pharmaceuticals Inc. from selling generic versions of the arthritis drug ... San Francisco Chronicle, 1 hour ago
BRIEF: US court delays Teva launch of generic Celebrex [Globes, Tel Aviv, Israel] - BusinessWeek, 1 day ago
US court delays Teva launch of generic Celebrex - Globes, 1 day ago
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ:CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for platelets. The INTERCEPT platelet system is approved for ex vivo ...Investor's Business Daily, 35 minutes ago Cerus' Intercept Blood System for plasma receives US FDA approval PharmaBiz, 17 hours ago Here Is Why Cerus Corporation (CERS) Stock Is Soaring Bidness Etc, 15 hours ago
The US Food and Drug Administration (FDA) announced the membership of the Pharmacy Compounding Advisory Committee (PCAC). The committee is comprised of 14 members - 12 voting and two non-voting - who will provide advice on scientific, technical and ...PharmaBiz, 19 hours ago Veloxis announces that it has filed an action against the Food and Drug Administration, seeking an order requiring FDA to grant EuroInvestor, 2 days ago Calorie Counts on Menu Boards May Help Us Eat Less Huffington Post, 3 days ago Veloxis Pharmaceuticals A/S : announces that it has filed an action against the Food and Drug Administration, seeking an order requiring FDA to grant final approval to Envarsus® XR. 4 Traders, 2 days ago
The U.S. Food and Drug administration has approved a new testaimed at helping doctors screen for coronary heart disease, especially in women, and in particular, black women, the agency announced . We hope the clearance of this test will improve ...UnitedHealthcare, 21 hours ago FDA Clears Test to Help Predict Risk of Coronary Heart Disease Diagnostic & Invasive Cardiology, 2 hours ago
EOS imaging reported that the U.S. Food and Drug Administration has approved hipEOS, a 3D hip arthroplasty planning software based on EOS stereo-radiographic 2D/3D imaging. According to a release from the company, hipEOS is the first offering of a ...Individual.com, 19 hours ago Sorin obtains FDA approval for Memo 3D ReChord annuloplasty ring Medical Devices Business Review, 16 hours ago Sorin : Announces FDA Clearance and First U.S. Implant of Memo 3D ReChord(TM) Annuloplasty Ring 4 Traders, 1 day ago Sorin Group Announces FDA Clearance and First U.S. Implant of Memo 3D ReChord(TM) Annuloplasty Ring TMC Net, 1 day ago
Researchers reported that their evaluation of an interventional X-ray guidance device approved by the US Food and Drug Administration (FDA) in 2013 has the potential to reduce the radiation exposure of...
Researchers reported that their evaluation of an interventional X-ray guidance device approved by the US Food and Drug Administration (FDA) in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy ...MedImaging.net, 18 hours ago New Imaging System Alternative to Intra-arterial Therapy (IAT) : A Boon to Liver Cancer Patients Med India, 3 weeks ago
CSL Behring announced it has submitted a biologics license application (BLA) to the United States Food and Drug Administration (FDA) for the marketing authorisation of its long-acting fusion protein linking recombinant coagulation factor IX with ...PharmaBiz, 20 hours ago
The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung cancer is expected to lead to over 150,000 deaths in the United States ...Science Daily, 20 hours ago Ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression Oncology Report, 1 day ago US FDA expands approved use of Eli Lilly's Cyramza to treat patients with NSCLC PharmaBiz, 2 days ago FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer (NSCLC) Medical News Today, 12 hours ago
HedgePath Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for the first investigational new drug (IND) application to start development of its proposed cancer treatment. The IND covers the company's clinical ...Pharmaceutical Business Review, 18 hours ago Pacira Pharma gets US FDA nod for changes in Exparel labeling PharmaBiz, 2 days ago Johns Hopkins Researchers Tapped by FDA to Examine Doctors Propensity to Prescribe Brand-Name Drugs Over Generic Health Canal, 2 days ago FDA changes labeling for drugs used during pregnancy, lactation Reuters, 2 weeks ago
Strides Arcolab Ltd has received the approval of the US Food and Drug Administration (FDA) for Calcitriol softgel tablets. The drug is used in the treatment of patients with kidney disease and vitamin D deficiency. The company will market ...4 Traders, 19 hours ago Strides Arcolab receives approval from US FDA for Calcitriol Softgel Capsules Equity Bulls, 2 days ago Strides Arcolab to manufacture Calcitriol Softgel Capsules for US market HDFC Securities, 2 days ago Strides Arcolab gets US drug regulator nod for Calcitriol softgel capsules Economic Times, 2 days ago
More from: , Arihant Capital...and 4 other sources
on your WebpageAdd Widget >Get your members hooked!